Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.420 CHF
366.36 M CHF
5.17 B CHF
852.24 M
About SMITH & NEPHEW PLC ORD USD0.20
Sector
Industry
CEO
Deepak S Nath
Website
Headquarters
Watford
Founded
1856
ISIN
GB0009223206
FIGI
BBG00LVGFFM9
Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.
Related stocks
S&N Long.New CFO and medical shares becoming attractive?
Idea only. Don't trade based on my ramblings.
Only risk 1R on any trade.
SNN, Smith & Nephew ADR - Trailing Stop after a breakoutNYSE:SNN
This level had resisted six times.
At the breakout the sellers were clearly few at that point and this was really a must for my strategies.
Let's follow the trend in trailing stop.
SN. Trend continuation?Seems like the pullback is nearly finishing and a beautiful triangle is forming.
Smith and Nephew potential If short term trend line and 1445 can hold good potential bullish If not longer term Trend line could offer good R/R
Medical Tech Mar17With Intuitive, Stryker all up at all time highs i'm hunting for medical robotics companies to acquire.
Smith & Nephew looking for a move below 29 to get long
seekingalpha.com
See all ideas
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
SNN5772776
Smith & Nephew plc 5.4% 20-MAR-2034Yield to maturity
5.28%
Maturity date
Mar 20, 2034
SNN5059246
Smith & Nephew plc 2.032% 14-OCT-2030Yield to maturity
5.09%
Maturity date
Oct 14, 2030
SNN5772775
Smith & Nephew plc 5.15% 20-MAR-2027Yield to maturity
4.40%
Maturity date
Mar 20, 2027
XS253247355
SMITH&NEPHEW 22/29Yield to maturity
2.99%
Maturity date
Oct 11, 2029
See all NPW1 bonds
Frequently Asked Questions
The current price of NPW1 is 12.092 CHF — it has decreased by −22.75% in the past 24 hours. Watch SMITH & NEPHEW PLC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange SMITH & NEPHEW PLC stocks are traded under the ticker NPW1.
We've gathered analysts' opinions on SMITH & NEPHEW PLC future price: according to them, NPW1 price has a max estimate of 15.80 CHF and a min estimate of 11.22 CHF. Watch NPW1 chart and read a more detailed SMITH & NEPHEW PLC stock forecast: see what analysts think of SMITH & NEPHEW PLC and suggest that you do with its stocks.
NPW1 reached its all-time high on Oct 6, 2021 with the price of 15.653 CHF, and its all-time low was 12.092 CHF and was reached on Jul 7, 2025. View more price dynamics on NPW1 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
NPW1 stock is 29.45% volatile and has beta coefficient of 1.00. Track SMITH & NEPHEW PLC stock price on the chart and check out the list of the most volatile stocks — is SMITH & NEPHEW PLC there?
Today SMITH & NEPHEW PLC has the market capitalization of 10.64 B, it has decreased by −0.70% over the last week.
Yes, you can track SMITH & NEPHEW PLC financials in yearly and quarterly reports right on TradingView.
SMITH & NEPHEW PLC is going to release the next earnings report on Aug 5, 2025. Keep track of upcoming events with our Earnings Calendar.
NPW1 earnings for the last half-year are 0.43 CHF per share, whereas the estimation was 0.42 CHF, resulting in a 1.92% surprise. The estimated earnings for the next half-year are 0.32 CHF per share. See more details about SMITH & NEPHEW PLC earnings.
SMITH & NEPHEW PLC revenue for the last half-year amounts to 2.71 B CHF, despite the estimated figure of 2.69 B CHF. In the next half-year revenue is expected to reach 2.32 B CHF.
NPW1 net income for the last half-year is 174.29 M CHF, while the previous report showed 192.32 M CHF of net income which accounts for −9.37% change. Track more SMITH & NEPHEW PLC financial stats to get the full picture.
SMITH & NEPHEW PLC dividend yield was 2.92% in 2024, and payout ratio reached 78.32%. The year before the numbers were 2.82% and 125.07% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Jul 20, 2025, the company has 18.46 K employees. See our rating of the largest employees — is SMITH & NEPHEW PLC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SMITH & NEPHEW PLC EBITDA is 1.34 B CHF, and current EBITDA margin is 26.32%. See more stats in SMITH & NEPHEW PLC financial statements.
Like other stocks, NPW1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SMITH & NEPHEW PLC stock right from TradingView charts — choose your broker and connect to your account.